He is a robotic and minimally invasive urologic surgeon who specializes in the treatment of cancers of the prostate, bladder, kidney and ureter. As a urology fellow at the National Cancer Institute of the National Institutes of Health, Vourganti collaborated with world experts in clinical care, basic science and engineering to develop new ideas and bring them to the clinic. Vourganti is especially interested in refining translational imaging-based platforms as well as minimally invasive, image-targeted focal therapy.